Given these observations, we investigated the effect of PARP inhibition on Cas9D10A-mediated cell-killing in MYCN-amplified (SK-N-BE(2)C and NGP) and MYCN non-amplified (SH-SY5Y) neuroblastoma cells. Here, MYCN is linked to neuroblastoma.